The use of flow perfusion culture and subcutaneous implantation with fibroblast-seeded PLLA-collagen 3D scaffolds for abdominal wall repair

Biomaterials

Volumn 31, Issue 15, 2010, Pages 4330-4340

  Pu, Fanrong ^a   Rhodes, Nicholas P ^a   Bayon, Yves ^b   Chen, Rui ^a   Brans, Gerben ^c   Benne, Remco ^c   Hunt, John A ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b MEDTRONIC INC   (United States)

^c Deer Park Business Centre   (Netherlands)

Author keywords

Fibroblasts; Flow perfusion bioreactor; Large complex abdominal wall defect; PLLA; Regenerative medicine; Tissue engineering

Indexed keywords

3D SCAFFOLDS; ABDOMINAL WALL DEFECTS; ANIMAL MODEL; COLLAGEN SCAFFOLDS; COLLAGEN SPONGE; DERMAL FIBROBLASTS; EXTRACELLULAR MATRIX PROTEIN; FLOW PERFUSION; FLOW PERFUSION BIOREACTOR; HYBRIDISATION; IMMUNOHISTOCHEMISTRY; IN-SITU; IN-VITRO; IN-VIVO; MECHANICALLY STABLE; OVER CURRENT; PERFUSION CONDITIONS; PERFUSION SYSTEM; PLLA; POLY(LACTIC ACID); REGENERATIVE MEDICINE; STABILISATION; STATE-OF-THE-ART PROCEDURES; STATIC CONDITIONS; TIME POINTS; TISSUE CONSTRUCTS; TISSUE DEFECTS;

BIOCONVERSION; BIOREACTORS; CELL CULTURE; CELL PROLIFERATION; COLLAGEN; DEFECTS; FIBROBLASTS; FLUORESCENCE MICROSCOPY; LACTIC ACID; ORGANIC ACIDS; REPAIR; THREE DIMENSIONAL; TISSUE; TISSUE ENGINEERING;

SCAFFOLDS;

COLLAGEN; COLLAGEN TYPE 1; COLLAGEN TYPE 3; GLUTARALDEHYDE; MOLECULAR SCAFFOLD; POLYLACTIC ACID; SCLEROPROTEIN;

ABDOMINAL WALL DEFECT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOREACTOR; CELL PROLIFERATION; CELL STRUCTURE; CELL SURVIVAL; CELL VIABILITY; CELLULAR DISTRIBUTION; CONTROLLED STUDY; FIBROBLAST; FLUORESCENCE IN SITU HYBRIDIZATION; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOHISTOCHEMISTRY; IMPLANTATION; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SCANNING ELECTRON MICROSCOPY; SKIN FIBROBLAST; TISSUE REPAIR;

ABDOMINAL WALL; ANIMALS; BIOREACTORS; CELL CULTURE TECHNIQUES; CELL SURVIVAL; COLLAGEN; FIBROBLASTS; HUMANS; LACTIC ACID; PERFUSION; POLYMERS; REGENERATION; SWINE; TISSUE CULTURE TECHNIQUES; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

ANIMALIA;

EID: 77949653921     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2010.02.010     Document Type: Article

References (42)

1. Kim H., Bruen K., Vargo D. Acellular dermal matrix in the management of high-risk abdominal wall defects. Am J Surg 2006, 192:705-709.
2. Patton J.H., Berry S., Kralovich K.A. Use of human acellular dermal matrix in complex and contaminated abdominal wall reconstructions. Am J Surg 2007, 193:360-363.
3. Ueno T., Pickett L.C., De La Fuente S.G., Lawson D.C., Pappas T.N. Clinical application of porcine small intestinal submucosa in the management of infected or potentially contaminated abdominal defects. J Gastrointest Surg 2004, 8:109-112.
4. Hirsch E.F. Repair of an abdominal wall defect after a salvage laparotomy for sepsis. J Am Coll Surg 2004, 198:324-328.
5. Joels C.S., Vanderveer A.S., Newcomb W.L., Lincourt A.E., Polhill J.L., Jacobs D.G., et al. Abdominal wall reconstruction after temporary abdominal closure: a ten-year review. Surg Innov 2006, 13:223-230.
6. Schachtrupp A., Fackeldey V., Klinge U., Hoer J., Tittel A., Toens C., et al. Temporary closure of the abdominal wall (laparostomy). Hernia 2002, 6:155-162.
7. Chang E.I., Foster R.D., Hansen S.L., Jazayeri L., Patti M.G. Autologous tissue reconstruction of ventral hernias in morbidly obese patients. Arch Surg 2007, 142:746-749.
8. Park A.E., Roth J.S., Kavic S.M. Abdominal wall hernia. Curr Probl Surg 2006, 43:326-375.
9. Valentin J.E., Badylak J.S., McCabe G.P., Badylak S.F. Extracellular matrix bioscaffolds for orthopaedic applications: a comparative histologic study. J Bone Joint Surg A 2006, 88:2673-2686.
10. Oberpenning F., Meng J., Yoo J.J., Atala A. De novo reconstitution of a functional mammalian urinary bladder by tissue engineering. Nat Biotechnol 1999, 17:149-155.
11. Lai J.-Y., Chang P.-Y., Lin J.-N. Body wall repair using small intestinal submucosa seeded with cells. J Pediatr Surg 2003, 38:1752-1755.
12. Atala A., Bauer S.B., Soker S., Yoo J.J., Retik A.B. Tissue-engineered autologous bladders for patients needing cystoplasty. Lancet 2006, 367:1241-1246.
13. Conconi M.T., Coppi P.D., Bellini S., Zara G., Sabatti M., Marzaro M., et al. Homologous muscle acellular matrix seeded with autologous myoblasts as a tissue-engineering approach to abdominal wall-defect repair. Biomaterials 2005, 26:2567-2574.
14. Freed L.E., Vunjak-Novakovic G., Biron R.J., Eagles D.B., Lesnoy D.C., Barlow S.K., et al. Biodegradable polymer scaffolds for tissue engineering. Nat Biotechnol 1994, 12:689-693. (N Y).
15. Lu L., Mikos A.G. The importance of new processing techniques in tissue engineering. MRS Bull 1996, 21:28-32.
16. Chen G., Ushida T., Tateishi T. Hybrid biomaterials for tissue engineering: a preparative method for PLA or PLGA-collagen hybrid sponges. Adv Mater 2000, 12:455-457.
17. Lutolf M.P., Hubbell J.A. Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering. Nat Biotechnol 2005, 23:47-55.
18. Gjorevski N., Nelson C.M. Bidirectional extracellular matrix signaling during tissue morphogenesis. Cytokine Growth Factor Rev 2009, 20:459-465.
19. Mooney D.J., Mikos A.G. Growing new organs. Sci Am 1999, 280:60-65.
20. Eugene B. Strategy for the selection of scaffolds for tissue engineering. Tissue Eng 1995, 1:163-179.
21. Kim B.S., Mooney D.J. Development of biocompatible synthetic extracellular matrices for tissue engineering. Trends Biotechnol 1998, 16:224-229.
22. Pei M., Solchaga L.A., Seidel J., Zeng L., Vunjak-Novakovic G., Caplan A.I., et al. Bioreactors mediate the effectiveness of tissue engineering scaffolds. FASEB J 2002, 16:1691-1694.
23. Agrawal C.M., Ray R.B. Biodegradable polymeric scaffolds for musculoskeletal tissue engineering. Biomed Mater Res 2001, 55:141-150.
24. Pariente J.L., Kim B.S., Atala A. In vitro biocompatibility evaluation of naturally derived and synthetic biomaterials using normal human bladder smooth muscle cells. J Urol 2002, 167:1867-1871.
25. Eckes B., Zigrino P., Kessler D., Holtkötter O., Shephard P., Mauch C., et al. Fibroblast-matrix interactions in wound healing and fibrosis. Matrix Biol 2000, 19:325-332.
26. Gabbiani G. The myofibroblast in wound healing and fibrocontractive diseases. J Pathol 2003, 200:500-503.
27. Toma J.G., Akhavan M., Fernandes K.J.L., Barnabeć-Heider F., Sadikot A., Kaplan D.R., et al. Isolation of multipotent adult stem cells from the dermis of mammalian skin. Nat Cell Biol 2001, 3:778-784.
28. Boonen K.J.M., Post M.J. The muscle stem cell niche: regulation of satellite cells during regeneration. Tissue Eng B 2008, 14:419-431.
29. Freed L.E., Vunjak-Novakovic G. Tissue engineering bioreactors. Principles of tissue engineering 2000, 143-156. Academic Press, New York. 2nd ed. R.P. Lanza, R. Langer, J.P. Vacanti (Eds.).
30. Vunjak-Novakovic G., Radisic M., Obradovic B. Cardiac tissue engineering: effects of bioreactor flow environment on tissue constructs. J Chem Technol Biotechnol 2006, 81:485-490.
31. Dennis R.G., Smith B., Philp A., Donnelly K., Baar K. Bioreactors for guiding muscle tissue growth and development. Adv Biochem Eng Biotechnol 2009, 112:39-79.
32. Bancroft G.N., Sikavitsas V.I., Van Den Dolder J., Sheffield T.L., Ambrose C.G., Jansen J.A., et al. Fluid flow increases mineralized matrix deposition in 3D perfusion culture of marrow stromal osteoblasts in a dose-dependent manner. Proc Natl Acad Sci U S A 2002, 99:12600-12605.
33. Afanasiev P., Thiollier A., Breysse M., Dubois J.L. Control of the textural properties of zirconium oxide. Top Catal 1999, 8:147-160.
34. Tinois E., Tiollier J., Gaucherand M., Dumas H., Tardy M., Thivolet J. In vitro and post-transplantation differentiation of human keratinocytes grown on the human type IV collagen film of a bilayered dermal substitute. Exp Cell Res 1991, 193:310-319.
35. Donadoni C., Corti S., Locatelli F., Papadimitriou D., Guglieri M., Strazzer S., et al. Improvement of combined FISH and immunofluorescence to trace the fate of somatic stem cells after transplantation. J Histochem Cytochem 2004, 52:1333-1339.
36. Amid P.K. Classification of biomaterials and their related complications in abdominal wall hernia surgery. Hernia 1997, 1:15-21.
37. Badylak S.F., Freytes D.O., Gilbert T.W. Extracellular matrix as a biological scaffold material: structure and function. Acta Biomater 2009, 5:1-13.
38. Badylak S., Kokini K., Tullius B., Whitson B. Strength over time of a resorbable bioscaffold for body wall repair in a dog model. J Surg Res 2001, 99:282-287.
39. Dejardin L.M., Arnoczky S.P., Ewers B.J., Haut R.C., Clarke R.B. Tissue-engineered rotator cuff tendon using porcine small intestine submucosa: histologic and mechanical evaluation in dogs. Am J Sports Med 2001, 29:175-184.
40. Fernandes K.J.L., McKenzie I.A., Mill P., Smith K.M., Akhavan M., Barnabé-Heider F., et al. A dermal niche for multipotent adult skin-derived precursor cells. Nat Cell Biol 2004, 6:1082-1093.
41. Kiseleva E.V., Chermnykh E.S., Vorotelyak E.A., Volozhin A.I., Vasiliev A.V., Terskikh V.V. Differentiation capacity of stromal fibroblast-like cells from human bone marrow, adipose tissue, hair follicle dermal papilla and derma. Cell Tissue Biol 2009, 3:42-49.
42. Haniffa M.A., Wang X.-N., Holtick U., Rae M., Isaacs J.D., Dickinson A.M., et al. Adult human fibroblasts are potent immunoregulatory cells and functionally equivalent to mesenchymal stem cells. J Immunol 2007, 179:1595-1604.